Compositions of quaternary ammonium compounds containing bioavailability enhancers
US8709476B2 · kind B2 · utility
0Cited by
63References
30Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 4, 2004 |
| Grant date | Apr 29, 2014 |
| Priority date | — |
| Expiry date | Mar 3, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An oral pharmaceutical dosage form with enhanced gastrointestinal permeability, comprising a therapeutic quaternary ammonium compound together with an organic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.